Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.

Br J Cancer · 1997 · PMC2223531 · PMID 9184183

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantP = 0.05actually significant

The difference in favour of etoposide phosphate was borderline significant: median 9.9 mg l(-1) h (95% CI 0.1-32.8 mg l(-1) h; P = 0.05).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.